CD8A and multiple sclerosis: In addition, patients after HSCT with lupus remission have a greater number of CD8+ Tregs (8) and anti-CD20 treatment in multiple sclerosis is also associated with increased CD8+ Tregs (9), indicating that CD8+ Tregs could alleviate immune response.